Evotec SE (ADR)

General ticker "EVO" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.4B (TTM average)

Evotec SE (ADR) does not follow the US Stock Market performance with the rate: -13.9%.

Estimated limits based on current volatility of 1.7%: low 3.19$, high 3.30$

Factors to consider:

  • Total employees count: 203 as of 2007
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.13$, 4.51$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.15$, 4.52$]

Financial Metrics affecting the EVO estimates:

  • Positive: with PPE of -11.3 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -0.98 <= 0.07
  • Positive: 42.60 < Shareholder equity ratio, % of 45.75 <= 64.25
  • Positive: Investing cash flow per share per price, % of 17.32 > -0.65
  • Positive: Inventory ratio change, % of -0.43 <= 0

Similar symbols

Short-term EVO quotes

Long-term EVO plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €781.43MM €796.97MM €757.26MM
Operating Expenses €828.93MM €939.49MM €892.57MM
Operating Income €-47.51MM €-142.52MM €-135.31MM
Non-Operating Income €-33.09MM €-51.45MM €12.00MM
Interest Expense €11.74MM €11.70MM €13.87MM
R&D Expense €68.53MM €50.86MM €74.33MM
Income(Loss) €-80.59MM €-193.98MM €-123.31MM
Taxes €3.32MM €2.10MM €-23.88MM
Profit(Loss)* €-83.91MM €-196.08MM €-99.43MM
Stockholders Equity €1,119.91MM €952.52MM €813.36MM
Inventory €30.89MM €31.12MM €29.30MM
Assets €2,252.47MM €1,912.50MM €1,778.00MM
Operating Cash Flow €36.44MM €18.22MM €-9.06MM
Capital expenditure €216.00MM €132.24MM €69.68MM
Investing Cash Flow €-13.29MM €-71.19MM €159.86MM
Financing Cash Flow €71.96MM €-161.42MM €-30.93MM
Earnings Per Share** €-0.24 €-0.55 €-0.28
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.